Amneal's methylphenidate is an AB-rated equivalent to the brand Concerta. The Amneal ANDA included all bioequivalence metrics recommended by FDA.
Methylphenidate hydrochloride ER tablets are now shipping to wholesalers, distributors and direct to the trade. All strengths are available in 90-ct bottles with a 30-ct size available upon request. The product is manufactured in the USA. at the Amneal plant in Brookhaven, New York.
Privately-held Amneal Pharmaceuticals is a US generics pharmaceutical manufacturer with more than 5,000 employees in North America, Asia and Europe, working together to bring high-quality affordable medicines to patients worldwide.
The company has significantly expanded its portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas.
Fresenius Kabi Introduces Leucovorin Calcium Injection, USP
FDA Approves Dr. Reddy's Tosymra 10 mg, in the US Market
Dr. Reddy's Laboratories Announces the Launch of Propofol Injectable Emulsion, USP in the US Market
Amerigen awarded US FDA's approval for generic mixed amphetamine salts, extended-release capsules
Pharmaceutics International names new president and CEO
Amneal wins US FDA approval for Rivastigmine Transdermal System
Premier Expands Effort to Supply Shortage Generic Drugs
Ferring Pharmaceuticals Adds Two Products to its Reproductive Health Portfolio in the US
China's Bio-Thera Solutions Partners with Cipla to Market Key Cancer Biosimilar
EpicGenetics Moves into New Facility, Expanding Capacity by 4X
Amneal Pharmaceuticals appoints David A. Buchen as SVP, chief legal officer and corporate secretary
Ironwood Pharmaceuticals and Allergan reach agreement to resolve Mylan LINZESS patent litigation
Teva and Amgen Resolve Ongoing Dispute Over Teva's Generic Cinacalet HCl Product